Gene Expression Profiling 

This integrated therapeutic and genomics technology enables AlphaGene to accelerate drug target discovery research efforts by providing the means to analyze many thousands of genes in a single experiment.

The Company's gene expression platform is designed to focus research efforts by rapidly identifying important gene targets. AlphaGene's biochip capability is readily expandable to include as many known or unknown gene targets on a single slide as are likely to be necessary for collaborative research programs.

Expression profiling using AlphaGene's discovery platform is well suited to the identification of differentially expressed human genes associated with disparate disease processes. 

The Company's technology is also amenable to the identification of genes that are regulated in response to drug treatments, mediate developmental processes, or are involved with repair and/or healing. Moreover, this technology is broadly applicable to primary tissues, cells grown in culture and non-human disease model systems. 

AlphaGene has already utilized its expression discovery platform to identify several novel human genes associated with Alzheimer's Disease and hypoxia (which is relevant to cell proliferation research for therapies to treat cancer) and is now extending these initial studies in order to identify other important disease-associated genes.